First Horizon Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
First Horizon Advisors's TXG Position: Q2 2025 in Review
First Horizon Advisors reduced its 10x Genomics (TXG) stake by 34% in Q2 2025, selling an estimated $8.45K and leaving 1,824 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.
First Horizon Advisors first reported a position in TXG in Q1 2021 and has held it in 18 quarters since. The position peaked at $82.8K in Q1 2023. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.
- First Horizon Advisors held 1,824 shares of 10x Genomics worth $21.1K as of Q2 2025.
- First Horizon Advisors sold 927 10x Genomics shares in Q2 2025, an estimated $8.45K.
- 10x Genomics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1398 holding.
- First Horizon Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 18 quarters since.
- First Horizon Advisors's 10x Genomics position peaked at $82.8K in Q1 2023.
- 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.